- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
Jim Cramer Says Stay Away From This Cybersecurity Company; He's Been 'Against Them The Whole Way Down'
October 11, 2022
From Benzinga
From Benzinga
Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11
October 10, 2022
From InvestorPlace
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
October 10, 2022
From Benzinga
From Benzinga
From Benzinga
These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?
September 29, 2022
From Motley Fool
A Shot of NVAX Stock Is NOT What Your Portfolio Needs
September 28, 2022
Tickers
NVAX
From InvestorPlace
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
From Benzinga
Ryder System, Harrow Health And Other Big Gainers From Tuesday
September 28, 2022
From Benzinga
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 27, 2022
From Benzinga
Canada to scrap mask mandate on planes, joining Japan, Hong Kong and U.A.E. in lifting COVID restrictions
September 27, 2022
From MarketWatch
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
From InvestorPlace
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
September 27, 2022
From Benzinga
Down 85%, Is There Any Hope for This Struggling Vaccine Stock?
September 26, 2022
From Motley Fool
Novavax Downgraded by JPMorgan Chase. Time to Sell?
September 25, 2022
From Motley Fool
From Benzinga
KB Home, Darden Restaurants And Other Big Losers From Thursday
September 23, 2022
From Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
September 23, 2022
From Benzinga
Why Novavax Stock Is Plunging This Week
September 22, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 22, 2022
From Benzinga
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
September 22, 2022
From Benzinga
Why Novavax Stock Hit a Fresh 52-Week Low Today
September 22, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022
September 22, 2022
From Benzinga
What Is Going on With Accenture (ACN) Stock Today?
September 22, 2022
From InvestorPlace
From Benzinga
Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement
September 22, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.